Literature DB >> 26511559

Cancer-fighting viruses win approval.

Heidi Ledford.   

Abstract

Mesh：

Year:  2015        PMID： 26511559     DOI： 10.1038/526622a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  37 in total

1.  A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma.

Authors:  Sarah Abdullahi; Melanie Jäkel; Sabine J Behrend; Katja Steiger; Geoffrey Topping; Teresa Krabbe; Alessio Colombo; Volker Sandig; Tobias S Schiergens; Wolfgang E Thasler; Jens Werner; Stefan F Lichtenthaler; Roland M Schmid; Oliver Ebert; Jennifer Altomonte
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

Review 2.  Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine.

Authors:  Kegan S Sunderland; Mingying Yang; Chuanbin Mao
Journal:  Angew Chem Int Ed Engl       Date:  2017-01-24       Impact factor: 15.336

3.  Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1.

Authors:  Chaohu Pan; Qiaomei Cai; Xiaorong Li; Lili Li; Liping Yang; Yu Chen; Junxiao Liu; Wancheng Liu; Meiling Gao; Tianqi Sui; Xiaoyang Wang; Huiming Fan; Jiayin Ruan; Yueyue Shi; Saihua Chen; Lucy S Cheng; Jiayong Liu; Heng Yang; Genhong Cheng
Journal:  Cell Mol Immunol       Date:  2022-01-05       Impact factor: 22.096

4.  NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.

Authors:  Yotam Bar-On; Yoav Charpak-Amikam; Ariella Glasner; Batya Isaacson; Alexandra Duev-Cohen; Pinchas Tsukerman; Alexander Varvak; Michal Mandelboim; Ofer Mandelboim
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

5.  Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy.

Authors:  Carmela Passaro; Quazim Alayo; Isabella De Laura; John McNulty; Korneel Grauwet; Hirotaka Ito; Vivek Bhaskaran; Marco Mineo; Sean E Lawler; Khalid Shah; Maria C Speranza; William Goins; Eric McLaughlin; Soledad Fernandez; David A Reardon; Gordon J Freeman; E Antonio Chiocca; Hiroshi Nakashima
Journal:  Clin Cancer Res       Date:  2018-10-02       Impact factor: 12.531

Review 6.  Adeno-associated virus (AAV) vectors in cancer gene therapy.

Authors:  Jorge L Santiago-Ortiz; David V Schaffer
Journal:  J Control Release       Date:  2016-01-12       Impact factor: 9.776

Review 7.  Vector engineering, strategies and targets in cancer gene therapy.

Authors:  Vijayata Singh; Nusrat Khan; Giridhara R Jayandharan
Journal:  Cancer Gene Ther       Date:  2021-04-15       Impact factor: 5.987

Review 8.  Microparticles: biogenesis, characteristics and intervention therapy for cancers in preclinical and clinical research.

Authors:  Yan Hu; Yajie Sun; Chao Wan; Xiaomeng Dai; Shuhui Wu; Pui-Chi Lo; Jing Huang; Jonathan F Lovell; Honglin Jin; Kunyu Yang
Journal:  J Nanobiotechnology       Date:  2022-04-13       Impact factor: 10.435

Review 9.  Cancer immunotherapy: the beginning of the end of cancer?

Authors:  Sofia Farkona; Eleftherios P Diamandis; Ivan M Blasutig
Journal:  BMC Med       Date:  2016-05-05       Impact factor: 8.775

10.  Recombinant mumps virus as a cancer therapeutic agent.

Authors:  Arun Ammayappan; Stephen J Russell; Mark J Federspiel
Journal:  Mol Ther Oncolytics       Date:  2016-08-10       Impact factor: 7.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.